DFX Intelligence

Data Factory

Genoptix

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:3edf5535-3fd9-44b2-bc41-6b20b4515985

Data as of Sep 15, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 19, 2026, 1:55 AM UTC and rebuilt at most every 15 minutes.

Relationships: 5
Dated events: 1
On other graphs: 1
Observed: Sep 15, 2026 to Sep 15, 2026
3 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Venture Capitalidentity

Genoptix

Venture-backed company · cited

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Owners: Ampersand Capital Partners, Ampersand Capital Partners and 1315 Capital, 1315 Capital
Add-ons on file: 1add-on transactions linked to this company on the graph
Add-ons evidenced: 1derived0 in 24 months, from sponsor and platform websites and press; record tier discovery, not independently verified
Latest add-on: Apr 30, 2018
Transactions: 1
Investors: 3

Transactions

Announced	Type	Headline	EV	Basis
Apr 30, 2018	Add on acquisition	Stockholders Approve Genoptix Acquisition of Rosetta Genomics	n/a	n/a

Investors

Investor	Class	Role	Control	Invested	Status
Ampersand Capital Partners	Buyout	unknown	unknown	n/a	exited
Ampersand Capital Partners and 1315 Capital	Hybrid manager	platform	unknown	n/a	active
1315 Capital	Buyout	unknown	unknown	n/a	exited

Relationships

Invested in (3)

← 1315 CapitalFirmunknown
factDFX's own graph, The subject's own site
← Ampersand Capital Partners and 1315 CapitalFirmplatform
factNews and newswire
← Ampersand Capital PartnersFirmunknown
factThe subject's own site

Add on of (1)

← Rosetta GenomicsCompany
Apr 30, 2018 to presentfactNews and newswire

Dated events

Occurred
Apr 30, 2018
Add-on acquired
Stockholders Approve Genoptix Acquisition of Rosetta Genomics
Rosetta Genomics News and newswireobserved 3 days ago

Provenance

Graph: Private Equity
Canonical id: dfx:pe:3edf5535-3fd9-44b2-bc41-6b20b4515985
First observed: Sep 15, 2026
Last observed: Sep 15, 2026 3 days ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Genoptix

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:3edf5535-3fd9-44b2-bc41-6b20b4515985

Data as of Sep 15, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 19, 2026, 1:55 AM UTC and rebuilt at most every 15 minutes.

Announced

Type

Headline

Basis

Apr 30, 2018

Add on acquisition

Stockholders Approve Genoptix Acquisition of Rosetta Genomics

n/a

Investor

Class

Role

Control

Invested

Status

Ampersand Capital Partners

Buyout

unknown

n/a

exited

Ampersand Capital Partners and 1315 Capital

Hybrid manager

platform

unknown

n/a

active

1315 Capital

Buyout

unknown

n/a

exited